This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Christopher Theile, PhD
Principal Scientist at Alnylam Pharmaceuticals


Christopher Theile is an oligonucleotide chemist whose research is primarily focused on delivery of siRNA molecules to the central nervous system. Chris has been at Alnylam since 2014 and his contributions have helped both Platform efforts to improve siRNA activity and delivery as well as supporting the development of clinical candidates. Chris received his B.S. degree at Bates College before earning his PhD at Boston College under Professor Larry McLaughlin, where he synthesized structurally constrained nucleosides. He also completed post-doctoral research at the Whitehead Institute for BioMedical Research studying sortase mediated peptide/protein ligations.

Agenda Sessions

  • Recent Advancements for the Delivery of siRNA's to the Central Nervous System